These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 11145152

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure-inhibitory activity relationship of plasmin and plasma kallikrein inhibitors.
    Tsuda Y, Tada M, Wanaka K, Okamoto U, Hijikata-Okunomiya A, Okamoto S, Okad Y.
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1457-63. PubMed ID: 11724238
    [Abstract] [Full Text] [Related]

  • 4. Active site-directed plasmin inhibitors: Extension on the P2 residue.
    Hidaka K, Gohda K, Teno N, Wanaka K, Tsuda Y.
    Bioorg Med Chem; 2016 Feb 15; 24(4):545-53. PubMed ID: 26732532
    [Abstract] [Full Text] [Related]

  • 5. Development of selective inhibitors against plasma kallikrein.
    Teno N, Wanaka K, Okada Y, Tsuda Y, Okamoto U, Hijikata-Okunomiya A, Naito T, Okamoto S.
    Chem Pharm Bull (Tokyo); 1991 Nov 15; 39(11):2930-6. PubMed ID: 1839246
    [Abstract] [Full Text] [Related]

  • 6. Development of plasma kallikrein selective inhibitors.
    Okada Y, Tsuda Y, Tada M, Wanaka K, Hijikata-Okunomiya A, Okamoto U, Okamoto S.
    Biopolymers; 1999 Nov 15; 51(1):41-50. PubMed ID: 10380351
    [Abstract] [Full Text] [Related]

  • 7. Development of plasmin-selective inhibitors and studies of their structure-activity relationship.
    Okada Y, Matsumoto Y, Tsuda Y, Tada M, Wanaka K, Hijikata-Okunomiya A, Okamoto S.
    Chem Pharm Bull (Tokyo); 2000 Feb 15; 48(2):184-93. PubMed ID: 10705502
    [Abstract] [Full Text] [Related]

  • 8. Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backbone.
    Fukumizu A, Tsuda Y, Wanaka K, Tada M, Okamoto S, Hijikata-Okunomiya A, Okada Y.
    Chem Pharm Bull (Tokyo); 1999 Aug 15; 47(8):1141-4. PubMed ID: 10478469
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of tripeptidic plasmin inhibitors with nitrile as warhead.
    Teno N, Otsubo T, Gohda K, Wanaka K, Sueda T, Ikeda K, Hijikata-Okunomiya A, Tsuda Y.
    J Pept Sci; 2012 Oct 15; 18(10):620-5. PubMed ID: 22961872
    [Abstract] [Full Text] [Related]

  • 10. Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationship.
    Teno N, Wanaka K, Okada Y, Taguchi H, Okamoto U, Hijikata-Okunomiya A, Okamoto S.
    Chem Pharm Bull (Tokyo); 1993 Jun 15; 41(6):1079-90. PubMed ID: 8370108
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
    Gilboa N, Villannueva GB, Fenton JW.
    Enzyme; 1988 Jun 15; 40(2-3):144-8. PubMed ID: 2971531
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A, Mennecier P, Lila C, de Nanteuil G, Verbeuren TJ.
    Thromb Haemost; 1997 Oct 15; 78(4):1221-7. PubMed ID: 9364988
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protease-inhibitory activities of leupeptin analogues.
    Saino T, Someno T, Ishii S, Aoyagi T, Umezawa H.
    J Antibiot (Tokyo); 1988 Feb 15; 41(2):220-5. PubMed ID: 2965694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.